个性化文献订阅>期刊> Current Topics in Medicinal Chemistry
 

Discovery and Development of a Potent and Highly Selective Small Molecule Muscarinic Acetylcholine Receptor Subtype I (mAChR 1 or M-1) Antagonist In Vitro and In Vivo Probe

  作者 Weaver, CD; Sheffler, DJ; Lewis, LM; Bridges, TM; Williams, R; Nalywajko, NT; Kennedy, JP; Mulder, MM; Jadhav, S; Aldrich, LA; Jones, CK; Marlo, J; Niswender, CM; Mock, MM; Zheng, F; Conn, PJ; Lindsley, CW  
  选自 期刊  Current Topics in Medicinal Chemistry;  卷期  2009年9-13;  页码  1217-1226  
  关联知识点  
 

[摘要]This article describes the discovery and development of the first highly selective, small molecule antagonist of the muscarinic acetylcholine receptor subtype I (mAChR1 or M-1). An M-1 functional, cell-based, calcium-mobilization assay identified three distinct chemical series with initial selectivity for M-1 versus M-4. An iterative parallel synthesis approach was employed to optimize all three series in parallel, which led to the development of novel microwave-assisted chemistry and provided important take home lessons for probe development projects. Ultimately, this effort produced VU0255035, a potent (IC50 = 130 nM) and selective (>75-fold vs. M-2-M-5 and >10 mu M vs. a panel of 75 GPCRs, ion channels and transporters) small molecule M-1 antagonist. Further profiling demonstrated that VU0255035 was centrally penetrant (Brain(AUC)/Plasma(AUC) of 0.48) and active in vivo, rendering it acceptable as both an in vitro and in vivo MLSCN/MLPCN probe molecule for studying and dissecting M-1 function.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内